Browsing: biotechnology

Biotech firm Neurxstem launches joint venture with UK to tackle Alzheimer’s, autism, addiction, and age-related cognitive decline using innovative brain health technology

The Regional Accelerator and Mentoring Program’s latest cohort features six innovative tech startups focused on biotechnology, controlled environment agriculture, and document management.

Decentralized Biotechnology Intelligence Holding Group Inc. (dBio) announces Bert Hoyt, former Nike VP & GM, as newest Board Advisor

Decentralized Biotechnology Intelligence Holding Group Inc. (dBio) announces Hubertus ‘Bert’ Hoyt as its newest Board Advisor, bringing over 32 years of sports industry experience to drive innovation in athlete performance and wellness technologies.

The global DNA microarray market is expected to experience significant growth between 2024 and 2031, driven by advancements in genomics research and increasing demand for personalized medicine.

WearOptimo, a health technology company, has formed an advisory board of experts in biotechnology, healthcare, and regulatory affairs. The board will guide the company’s development of Microwearable sensors, starting with a focus on the sports market.

BioVaxys Technology Corp. will present its latest developments at the Emerging Growth Conference.

The SALSA Symposium ‘Make and Measure: Interfaces’ will be held from September 10-12, 2025, at the School of Analytical Sciences Adlershof in Berlin. The symposium will address challenges and solutions related to interfaces in various applications, including surface functionalization, electrochemistry, and complex biological systems.

Glaukos Corporation, a global leader in ophthalmic pharmaceuticals and medical technology, has chosen Huntsville, Alabama, for its new multimillion-dollar facility. The project signifies a major investment in the region and strengthens Huntsville’s position in the biotech sector.

BioVaxys Technology Corp. will present at the Emerging Growth Conference on January 16, 2025, offering investors and analysts a real-time interactive session with the company’s leadership.